StockData

inTEST vs Kewaunee Scientific

INTT and KEQU side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How INTT and KEQU compare

inTEST is the larger company, worth 1.6 times as much as Kewaunee Scientific ($160M against $98.5M).

On earnings, Kewaunee Scientific is cheaper: it trades at 12.3× trailing earnings, against 41.7× for inTEST.

inTEST grew revenue faster over the last twelve months (16.6% versus 5.3% for Kewaunee Scientific).

Kewaunee Scientific keeps more of each dollar of sales as profit, with a net margin of 3.0% compared with 2.7% at inTEST.

Kewaunee Scientific scores higher on the StockData Score (14 against 11 for inTEST), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricINTTKEQU
Size and price
Market cap$160M$98.5M
Share price$12.50$34.01
Change, 1 year65.8%−15.9%
Change, 5 years−20.3%162%
Beta (5Y)1.380.83
Employees407–
StockData Score
Total score1114 (better)
Valuation score15 (better)
Growth score3 (better)1
Performance score24 (better)
Health score5 (better)4
Dividend score00
Valuation
P/E41.7×12.3× (better)
P/S1.2×0.4× (better)
P/B1.5×1.3× (better)
EV/EBITDA13.1×5.2× (better)
P/FCF–9.1×
PEG–0.09
FCF yield−0.15%11.0% (better)
Fair value$11.68$75.70
Margin of safety−7.0%55.1% (better)
Growth
Revenue growth (TTM)16.6% (better)5.3%
Revenue growth, 5Y average16.2% (better)13.8%
Net income growth (TTM)–−33.1%
EPS growth (TTM)–−33.2%
Profitability
Gross margin44.2% (better)28.6%
Operating margin3.3%5.4% (better)
Net margin2.7%3.0% (better)
FCF margin−0.17%3.9% (better)
Return on equity3.5%11.6% (better)
Return on invested capital4.0%13.1% (better)
Financial health
Debt / equity0.05 (better)0.25
Net debt / EBITDA−1.390.50 (better)
Interest coverage13.3× (better)4.4×
Current ratio2.63 (better)2.20
Altman Z-score4.24 (better)3.41
Piotroski F-score5 (better)4
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions67.3%41.4%
Held by insiders5.7%16.1%
Insider net buying, 12 months−$57.8K (better)−$293K
Short interest, % of float2.8%1.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.